Bicycle Therapeutics Cash Flow Statement (2018-2026) | BCYC

Cash Flow Statement Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
-17.91M-14.68M-18.02M-27.56M-26.88M-28.39M-34.95M-39.06M-42.60M-49.90M-45.83M-26.51M-39.81M-50.85M127.79M-60.74M-78.95M-59.10M204.47M-60.83M
Depreciation and Depletion (Quarter)
0.30M0.30M0.40M0.40M0.60M1.30M1.50M1.60M1.60M1.70M1.60M1.70M1.60M
Share-based Compensation (Quarter)
2.58M2.69M3.00M10.20M5.67M5.37M5.54M9.04M8.19M7.43M7.81M9.28M9.26M9.20M10.33M9.61M9.44M8.77M11.65M6.93M
Deferred Taxes (Quarter)
-0.75M-0.87M-1.02M-2.34M-2.11M-1.58M7.27M-0.28M-0.77M-0.11M-3.31M-1.03M-1.32M-0.33M-0.05M0.84M-0.24M
Gains from Sales and Divestitures (Quarter)
0.04M0.04M0.04M0.04M0.06M0.08M0.10M0.12M
Gains from Investment Securities (Quarter)
2.20M0.08M-0.01M3.12M0.20M0.10M1.02M4.57M0.10M2.10M-0.00M1.00M3.60M0.10M-0.99M1.77M1.41M1.79M0.05M0.07M
Non-cash Items (Quarter)
2.17M2.18M207.01M2.75M18.51M43.63M71.00M3.78M4.08M4.33M21.92M61.56M30.75M5.09M9.56M6.02M2.66M6.62M6.64M1.70M
Cash from Operations (Quarter)
-12.37M21.72M-10.44M-26.40M-23.53M-5.87M-30.31M-46.41M34.10M-1.02M-47.29M-70.87M-44.63M-39.83M-9.40M-86.37M-72.79M-71.17M-19.35M-65.92M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.34M0.34M0.41M0.42M0.62M1.26M1.39M1.56M1.65M1.69M1.65M1.66M1.64M2.17M1.70M1.63M1.70M1.76M1.34M1.13M
Change in Working Capital
Change in Receivables (Quarter)
-2.02M1.00M-0.99M10.34M-9.69M1.99M-2.52M-49.84M49.88M0.13M
Change in Account Payables (Quarter)
2.53M-1.96M0.93M-0.26M1.60M3.59M-2.37M-2.00M2.02M3.81M4.17M-5.92M-0.43M-1.24M10.69M-5.02M6.10M-5.07M-2.88M-3.84M
Change in Accured Expenses (Quarter)
1.25M0.08M1.71M-2.34M5.55M2.29M6.87M-3.13M11.55M-2.33M-3.69M-5.41M1.79M9.58M3.75M-8.21M9.18M1.12M2.00M-2.35M
Investing Activities
Capital Expenditures (Quarter)
0.17M0.17M1.07M4.76M9.80M2.98M1.45M2.10M0.28M0.50M0.05M0.01M0.42M0.43M0.37M0.60M0.50M0.67M0.57M0.71M
Cash from Investing Activities (Quarter)
-0.17M-0.17M-1.07M-4.76M-9.80M-2.98M-1.45M-2.10M-0.28M-0.50M-0.05M-0.01M-0.42M-0.43M-0.37M-0.60M-0.50M-0.67M-0.57M-0.71M
Financing Activities
Other financing activities (Quarter)
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
13.98M-67.84M286.08M0.45M0.20M0.16M4.90M0.00M12.10M19.40M0.01M1.87M4.50M0.91M536.84M0.00M0.00M0.00M0.03M0.01M
Misc.
Cash from Financing Activities (Quarter)
15.55M40.45M190.66M0.45M0.20M0.16M5.89M2.72M12.29M234.63M0.39M1.87M549.61M-31.93M0.20M-0.04M-0.04M-0.03M-0.01M-0.05M
Exchange Rate Effect (Quarter)
-0.17M-1.21M-0.01M-0.60M-1.47M-2.60M3.55M0.45M0.51M-0.90M1.29M-0.42M-0.19M1.70M-1.78M0.47M1.81M-1.25M-0.22M-1.94M
Change in Cash (Quarter)
2.84M60.79M179.16M-31.31M-34.60M-11.30M-22.32M-45.34M46.62M232.20M-45.66M-69.43M504.37M-70.50M-11.34M-86.55M-71.52M-73.13M-20.16M-68.64M
Free Cash Flow (Quarter)
-12.54M21.55M-11.50M-31.16M-33.33M-8.86M-31.76M-48.51M33.82M-1.53M-47.34M-70.88M-45.05M-40.27M-9.76M-86.97M-73.28M-71.85M-19.92M-66.64M
Net Cash Flow (Quarter)
3.01M62.00M179.16M-30.71M-33.13M-8.70M-25.87M-45.79M46.11M233.10M-46.95M-69.01M504.56M-72.20M-9.56M-87.02M-73.33M-71.88M-19.93M-66.69M